Planning around staff shortages in radiology might seem like a future inevitability for departmental directors, British researchers wrote in a Radiography study published this month. But employees’ greatest source of psychological stress doesn’t stem from a lack of colleagues—it comes from the uncertainty of a constantly shifting job market.

Researchers from Cleveland Clinic have discovered a new subtype of multiple sclerosis (MS), according to research published in Lancet Neurology. These findings, they said, highlight the importance of developing more sensitive imaging techniques for real-time evaluations of brain pathology.

Physicians who have a personal connection to cancer are nearly 18 percent more likely to act against established guidelines and recommend cancer screening for low-risk patients, specifically ovarian cancer screening in women, according to the Journal of Women’s Health.  

One Medical Group, a primary care group with offices in San Francisco, New York, Seattle and other cities, has closed a $350 million investment from the Carlyle Group, a private equity group based in Washington, D.C., TechCrunch reported.

Medicare could be saving a lot of cash by switching to generic constituents for some drugs—maybe as much as a billion dollars.
A recent study estimated spending in 2016 on 29 brand-name combination products would have been $925 million more than spending for generic counterparts.

Screening mammography is a reasonable surveillance tool for breast cancer patients treated with mastectomy and breast reconstruction with autologous myocutaneous flaps (AMFs), according to new research published in Radiology. Mammography provides little additional value, however, if the patient had reconstruction after a prophylactic mastectomy.

Nearly 20 percent of U.S. hospitals are at risk of potential closure or are in weak shape, according to a recent report from Morgan Stanley.

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors, an independent nonprofit organization authorized by Congress, has approved $85 million for 16 new studies to improve care and outcomes for several conditions.